Literature DB >> 8565291

A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis.

A E Kingston1, C A Hicks, M J Colston, M E Billingham.   

Abstract

The effects of a mycobacterial 71-kD hsp antigen have been investigated for its ability to modulate arthritis in rats. Subcutaneous injection (base of tail) of increasing amounts of hsp71 from Mycobacterium tuberculosis (MTB) produced dose-dependent differential inhibitory effects on induction of arthritis by MTB and CP20961 in rats. As little as 1 microgram of the hsp71 produced a reduction in MTB arthritis, whereas complete protection was observed when 50 micrograms were administered. When 71-kD-treated rats were challenged with CP20961, all developed reduced symptoms of arthritis compared with control rats, but in this model no complete protection was observed over the dose range studied. The effects of 71-kD pretreatment on collagen II arthritis were not significant, but in general symptoms of arthritis were milder than in the control group. The same pattern of results was observed previously when hsp65 was used in the different models. These results show that the modulatory effects of hsp on adjuvant arthritis are not restricted to the hsp65 series, but are also mediated by a member of the hsp70 family.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565291      PMCID: PMC2200306          DOI: 10.1046/j.1365-2249.1996.929628.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  Genetic vaccination against tuberculosis.

Authors:  D B Lowrie; C L Silva; R E Tascon
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis.

Authors:  César Rodríguez-Narciso; Mayra Pérez-Tapia; Rosa María Rangel-Cano; Celio L Silva; Mariana Meckes-Fisher; Rafael Salgado-Garciglia; Sergio Estrada-Parra; Rodolfo López-Gómez; Iris Estrada-García
Journal:  Transgenic Res       Date:  2010-06-06       Impact factor: 2.788

3.  HSP60, HSP70 in the pathogenesis of Kawasaki disease: implication and action.

Authors:  W Lu; P Cheng; S Chen
Journal:  J Tongji Med Univ       Date:  1998

4.  Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis.

Authors:  Chih-Te Charles Wu; Liang-Shiou Ou; Kuo-Wei Yeh; Wen-I Lee; Jing-Long Huang
Journal:  Clin Rheumatol       Date:  2011-02-22       Impact factor: 2.980

Review 5.  The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal.

Authors:  Min-Nung Huang; Hua Yu; Kamal D Moudgil
Journal:  Semin Arthritis Rheum       Date:  2009-12-06       Impact factor: 5.532

6.  The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?

Authors:  A Graham Pockley; Stuart K Calderwood; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2009-04-09       Impact factor: 3.667

Review 7.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Mycobacterial heat shock protein 70 induces interleukin-10 production: immunomodulation of synovial cell cytokine profile and dendritic cell maturation.

Authors:  T Detanico; L Rodrigues; A C Sabritto; M Keisermann; M E Bauer; H Zwickey; C Bonorino
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 9.  The determinants of susceptibility/resistance to adjuvant arthritis in rats.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Arthritis Res Ther       Date:  2009-08-07       Impact factor: 5.156

10.  IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis.

Authors:  Lotte Wieten; Suzanne E Berlo; Corlinda B Ten Brink; Peter J van Kooten; Mahavir Singh; Ruurd van der Zee; Tibor T Glant; Femke Broere; Willem van Eden
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.